An anonymous director reports

MEDBRIGHT AI INVESTMENTS INC. ANNOUNCES LIFE & SPECIAL WARRANT OFFERING UP TO APPROXIMATELY C$2,800,000

Medbright AI Investments Inc. has entered into an agreement with Canaccord Genuity Corp. to act as sole bookrunner and lead agent in connection with the company's offering (as defined below). The lead agent, on behalf of a syndicate including Beacon Securities Ltd. and PI Financial Corp., will assist the company on (a) a commercially reasonable efforts agency basis private placement offering (LIFE offering) of up to 6,994,887 units of the company at a price of 20 cents per LIFE unit for gross proceeds of up to $1,398,977.40; and (b) a commercially reasonable efforts agency basis private placement offering of up to seven million special warrants of the company at a price of 20 cents per special warrant for gross proceeds of up to $1.4-million. Each special warrant shall be exercisable for one unit of the company at no additional cost.

Each LIFE unit will consist of one common share of the company and one-half of one common share purchase warrant of the company. Each special warrant unit will consist of one common share and one warrant. Each warrant will entitle the holder thereof to purchase one common share for a period of 24 months following the closing date (as defined below) at an exercise price of 30 cents per warrant share. The warrants will be issued pursuant to the terms of a warrant indenture to be entered into between the company and a warrant trustee.

The LIFE offering has been structured to take advantage of the listed issuer financing exemption from prospectus requirements in Part 5A of National Instrument 45-106 -- Prospectus Exemptions, whereby shares issued pursuant to the exemption are freely tradeable listed equity securities not subject to any hold period (see below). The LIFE offering will be conducted in all the provinces of Canada, except Quebec, under the exemption. The special warrant offering will be conducted in all the provinces of Canada, except Quebec, pursuant to the accredited investor exemption from prospectus requirements in Part 2.3 of NI 45-106. The offering may be conducted in the United States pursuant to exemptions from the registration requirements under Rule 144A and/or Regulation D of the United States Securities Act of 1933, as amended, subject to receipt of all necessary regulatory approvals, and in those other jurisdictions outside of Canada and the United States provided it is understood that no prospectus filing or comparable obligation arises in such other jurisdiction. The LIFE units will not be subject to resale restrictions pursuant to applicable Canadian securities laws. The special warrant units will be subject to a statutory hold period of four months, in accordance with applicable Canadian securities laws.

There is an offering document relating to the LIFE offering that can be accessed under the company's profile at SEDAR+ and on the company's website. Prospective investors should read the offering document before making an investment decision.

The net proceeds of the offering will be used for business development, general working capital, other general corporate purposes, and sales and marketing activities as described in the offering document.

The offering is anticipated to close on or about Feb. 7, 2024, or such other date as may be agreed upon by the company and the lead agent, and completion of the offering is subject to certain conditions including, but not limited to, the receipt of all necessary approvals, including the approval of the Canadian Securities Exchange.

About Medbright AI Investments Inc.

Medbright AI Investments is a capital allocator that invests in diversified industries, including technology and health care. Investments may include equity, debt or other securities. These include both public and private companies and control-stake acquisitions. Medbright has a focus on significant near-term and midterm high-quality opportunities with strong return potentials while maintaining commitment to governance.

We seek Safe Harbor.